Cargando…
Comparing actual and forecasted numbers of unique patients dispensed select medications for opioid use disorder, opioid overdose reversal, and mental health, during the COVID-19 pandemic, United States, January 2019 to May 2020
BACKGROUND: COVID-19 community mitigation measures (e.g., stay-at-home orders) may worsen mental health and substance use-related harms such as opioid use disorder and overdose and limit access to medications for these conditions. We used nationally-representative data to assess dispensing of select...
Autores principales: | Jones, Christopher M., Guy, Gery P., Board, Amy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7787058/ https://www.ncbi.nlm.nih.gov/pubmed/33421802 http://dx.doi.org/10.1016/j.drugalcdep.2020.108486 |
Ejemplares similares
-
Opioid Antagonists
from the Orvinol Series as Potential
Reversal Agents for Opioid Overdose
por: Disney, Alex, et al.
Publicado: (2022) -
Trends in Out-of-Pocket Costs for and Characteristics of Pharmacy-Dispensed Buprenorphine Medications for Opioid Use Disorder Treatment by Type of Payer, 2015 to 2020
por: Strahan, Andrea E., et al.
Publicado: (2023) -
State-to-State Variation in Opioid Dispensing Changes Following the Release of the 2016 CDC Guideline for Prescribing Opioids for Chronic Pain
por: Lyu, Xiru, et al.
Publicado: (2023) -
Characteristics of Hydroxychloroquine Dispensing in the United States, January to May 2020
por: Levin, Zachary, et al.
Publicado: (2021) -
Association of Household Opioid Availability With Opioid Overdose
por: Hendricks, Michelle A., et al.
Publicado: (2023)